Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
or

Enanta Pharmaceutica (ENTA)

Enanta Pharmaceutica (ENTA)
4.10 x 5 6.19 x 1
Post-market by (Cboe BZX)
5.10 +0.17 (+3.45%) 04/17/25 [NASDAQ]
4.10 x 5 6.19 x 1
Post-market 5.10 unch (unch) 16:02 ET
Quote Overview for Thu, Apr 17th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
4.83
Day High
5.23
Open 4.87
Previous Close 4.93 4.93
Volume 183,400 183,400
Avg Vol 266,515 266,515
Stochastic %K 55.95% 55.95%
Weighted Alpha -71.08 -71.08
5-Day Change +0.84 (+19.72%) +0.84 (+19.72%)
52-Week Range 4.09 - 17.24 4.09 - 17.24
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 108,798
  • Shares Outstanding, K 21,333
  • Annual Sales, $ 67,640 K
  • Annual Income, $ -116,050 K
  • EBIT $ -110 M
  • EBITDA $ -109 M
  • 60-Month Beta 0.69
  • Price/Sales 1.55
  • Price/Cash Flow N/A
  • Price/Book 0.94

Options Overview Details

View History
  • Implied Volatility 145.25% ( +30.77%)
  • Historical Volatility 66.73%
  • IV Percentile 70%
  • IV Rank 49.51%
  • IV High 273.66% on 03/17/25
  • IV Low 19.34% on 08/27/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 20
  • Volume Avg (30-Day) 37
  • Put/Call OI Ratio 0.33
  • Today's Open Interest 1,032
  • Open Int (30-Day) 831

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -1.16
  • Number of Estimates 3
  • High Estimate -0.98
  • Low Estimate -1.42
  • Prior Year -1.47
  • Growth Rate Est. (year over year) +21.09%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.09 +24.69%
on 04/09/25
Period Open: 6.10
6.54 -22.02%
on 03/20/25
-1.00 (-16.39%)
since 03/17/25
3-Month
4.09 +24.69%
on 04/09/25
Period Open: 5.25
8.76 -41.78%
on 02/24/25
-0.15 (-2.86%)
since 01/17/25
52-Week
4.09 +24.69%
on 04/09/25
Period Open: 14.00
17.24 -70.41%
on 07/15/24
-8.90 (-63.57%)
since 04/17/24

Most Recent Stories

More News
Enanta Pharmaceuticals: Fiscal Q1 Earnings Snapshot

Enanta Pharmaceuticals: Fiscal Q1 Earnings Snapshot

ENTA : 5.10 (+3.45%)
Insider Sale: Chief Product Strategy Officer of $ENTA (ENTA) Sells 2,283 Shares

Tara Lynn Kieffer, the Chief Product Strategy Officer of $ENTA ($ENTA), sold 2,283 shares of the company on 12-06-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately...

ENTA : 5.10 (+3.45%)
Enanta Pharmaceuticals: Fiscal Q4 Earnings Snapshot

Enanta Pharmaceuticals: Fiscal Q4 Earnings Snapshot

ENTA : 5.10 (+3.45%)
Enanta Pharmaceuticals: Fiscal Q3 Earnings Snapshot

Enanta Pharmaceuticals: Fiscal Q3 Earnings Snapshot

ENTA : 5.10 (+3.45%)
Enanta Pharmaceuticals: Fiscal Q2 Earnings Snapshot

Enanta Pharmaceuticals: Fiscal Q2 Earnings Snapshot

ENTA : 5.10 (+3.45%)
Enanta Pharmaceuticals: Fiscal Q1 Earnings Snapshot

Enanta Pharmaceuticals: Fiscal Q1 Earnings Snapshot

ENTA : 5.10 (+3.45%)
Enanta Pharmaceuticals: Fiscal Q4 Earnings Snapshot

Enanta Pharmaceuticals: Fiscal Q4 Earnings Snapshot

ENTA : 5.10 (+3.45%)
Why Shares of Enanta Pharmaceuticals Are Dropping Tuesday

The company saw a slight revenue decline in its fiscal 2023 third-quarter earnings report.

ENTA : 5.10 (+3.45%)
JEF : 42.84 (+0.56%)
ABBV : 172.99 (+0.76%)
Enanta Pharmaceuticals: Fiscal Q3 Earnings Snapshot

Enanta Pharmaceuticals: Fiscal Q3 Earnings Snapshot

ENTA : 5.10 (+3.45%)
Enanta Pharmaceuticals: Fiscal Q2 Earnings Snapshot

Enanta Pharmaceuticals: Fiscal Q2 Earnings Snapshot

ENTA : 5.10 (+3.45%)

Business Summary

Enanta Pharmaceuticals, Inc. is a biotechnology company. It engages in the research and development of molecule drugs for the treatment of infectious diseases such as hepatitis C virus, respiratory tract infections, intravenous and oral treatments. Enanta Pharmaceuticals, Inc. is headquartered in Watertown,...

See More

Key Turning Points

3rd Resistance Point 5.67
2nd Resistance Point 5.45
1st Resistance Point 5.27
Last Price 5.10
1st Support Level 4.88
2nd Support Level 4.66
3rd Support Level 4.48

See More

52-Week High 17.24
Fibonacci 61.8% 12.21
Fibonacci 50% 10.66
Fibonacci 38.2% 9.11
Last Price 5.10
52-Week Low 4.09

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro